These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
540 related articles for article (PubMed ID: 31730182)
1. Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease. Lubeck D; Agodoa I; Bhakta N; Danese M; Pappu K; Howard R; Gleeson M; Halperin M; Lanzkron S JAMA Netw Open; 2019 Nov; 2(11):e1915374. PubMed ID: 31730182 [TBL] [Abstract][Full Text] [Related]
2. Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis. Kuznik A; Habib AG; Munube D; Lamorde M BMC Health Serv Res; 2016 Jul; 16():304. PubMed ID: 27461265 [TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States. Herring WL; Gallagher ME; Shah N; Morse KC; Mladsi D; Dong OM; Chawla A; Leiding JW; Zhang L; Paramore C; Andemariam B Pharmacoeconomics; 2024 Jun; 42(6):693-714. PubMed ID: 38684631 [TBL] [Abstract][Full Text] [Related]
4. Lifetime distributional effects of Social Security retirement benefits. Smith K; Toder E; Iams H Soc Secur Bull; 2003-2004; 65(1):33-61. PubMed ID: 15218634 [TBL] [Abstract][Full Text] [Related]
5. Social Vulnerability and Sickle Cell Disease Mortality in the US. Tan JY; San BJ; Yeo YH; Chan KH; Shaaban HS; Ezekwudo DE; Idowu M JAMA Netw Open; 2024 Sep; 7(9):e2440599. PubMed ID: 39348116 [TBL] [Abstract][Full Text] [Related]
6. The income-associated burden of disease in the United States. Muennig P; Franks P; Jia H; Lubetkin E; Gold MR Soc Sci Med; 2005 Nov; 61(9):2018-26. PubMed ID: 15913866 [TBL] [Abstract][Full Text] [Related]
7. Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis. Basu A; Winn AN; Johnson KM; Jiao B; Devine B; Hankins JS; Arnold SD; Bender MA; Ramsey SD Ann Intern Med; 2024 Feb; 177(2):155-164. PubMed ID: 38252942 [TBL] [Abstract][Full Text] [Related]
8. Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance. Johnson KM; Jiao B; Ramsey SD; Bender MA; Devine B; Basu A Blood Adv; 2023 Feb; 7(3):365-374. PubMed ID: 35575558 [TBL] [Abstract][Full Text] [Related]
9. Prevalence, Mortality, and Access to Care for Chronic Kidney Disease in Medicaid-Enrolled Adults With Sickle Cell Disease in California: Retrospective Cohort Study. Valle J; Lebensburger JD; Garimella PS; Gopal S JMIR Public Health Surveill; 2024 Jul; 10():e57290. PubMed ID: 39008353 [TBL] [Abstract][Full Text] [Related]
10. Measuring the COVID-19 Mortality Burden in the United States : A Microsimulation Study. Reif J; Heun-Johnson H; Tysinger B; Lakdawalla D Ann Intern Med; 2021 Dec; 174(12):1700-1709. PubMed ID: 34543588 [TBL] [Abstract][Full Text] [Related]
11. Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study. Tomic D; Morton JI; Chen L; Salim A; Gregg EW; Pavkov ME; Arffman M; Balicer R; Baviera M; Boersma-van Dam E; Brinks R; Carstensen B; Chan JCN; Cheng YJ; Fosse-Edorh S; Fuentes S; Gardiner H; Gulseth HL; Gurevicius R; Ha KH; Hoyer A; Jermendy G; Kautzky-Willer A; Keskimäki I; Kim DJ; Kiss Z; Klimek P; Leventer-Roberts M; Lin CY; Lopez-Doriga Ruiz P; Luk AOY; Ma S; Mata-Cases M; Mauricio D; McGurnaghan S; Imamura T; Paul SK; Peeters A; Pildava S; Porath A; Robitaille C; Roncaglioni MC; Sugiyama T; Wang KL; Wild SH; Yekutiel N; Shaw JE; Magliano DJ Lancet Diabetes Endocrinol; 2022 Nov; 10(11):795-803. PubMed ID: 36183736 [TBL] [Abstract][Full Text] [Related]
12. Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries. Jiao B; Johnson KM; Ramsey SD; Bender MA; Devine B; Basu A Blood Adv; 2023 Jul; 7(13):3276-3283. PubMed ID: 36929166 [TBL] [Abstract][Full Text] [Related]
13. Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs. Blinder MA; Vekeman F; Sasane M; Trahey A; Paley C; Duh MS Pediatr Blood Cancer; 2013 May; 60(5):828-35. PubMed ID: 23335275 [TBL] [Abstract][Full Text] [Related]
14. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. Murray CJ; Lopez AD Lancet; 1997 May; 349(9062):1347-52. PubMed ID: 9149696 [TBL] [Abstract][Full Text] [Related]
15. Distributional Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease in the United States. Goshua G; Calhoun C; Ito S; James LP; Luviano A; Krishnamurti L; Pandya A Ann Intern Med; 2023 Jun; 176(6):779-787. PubMed ID: 37247420 [TBL] [Abstract][Full Text] [Related]
16. Impact of the 1990 Hong Kong legislation for restriction on sulfur content in fuel. Wong CM; Rabl A; Thach TQ; Chau YK; Chan KP; Cowling BJ; Lai HK; Lam TH; McGhee SM; Anderson HR; Hedley AJ Res Rep Health Eff Inst; 2012 Aug; (170):5-91. PubMed ID: 23316618 [TBL] [Abstract][Full Text] [Related]
17. Effects of covid-19 pandemic on life expectancy and premature mortality in 2020: time series analysis in 37 countries. Islam N; Jdanov DA; Shkolnikov VM; Khunti K; Kawachi I; White M; Lewington S; Lacey B BMJ; 2021 Nov; 375():e066768. PubMed ID: 34732390 [TBL] [Abstract][Full Text] [Related]
18. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013. Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA; MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673 [TBL] [Abstract][Full Text] [Related]
19. The Association Between Income and Life Expectancy in the United States, 2001-2014. Chetty R; Stepner M; Abraham S; Lin S; Scuderi B; Turner N; Bergeron A; Cutler D JAMA; 2016 Apr; 315(16):1750-66. PubMed ID: 27063997 [TBL] [Abstract][Full Text] [Related]